Post-transcriptional Regulation of Erythropoiesis

Overview

Journal Blood Sci

Date 2023 Aug 7

PMID 37546708

Authors

Yanan Li

Haihang Zhang

Bin Hu

Pan Wang

Wei Wang

Jing Liu

Affiliations

Soon will be listed here.

Abstract

Erythropoiesis is a complex, precise, and lifelong process that is essential for maintaining normal body functions. Its strict regulation is necessary to prevent a variety of blood diseases. Normal erythropoiesis is precisely regulated by an intricate network that involves transcription levels, signal transduction, and various epigenetic modifications. In recent years, research on post-transcriptional levels in erythropoiesis has expanded significantly. The dynamic regulation of splicing transitions is responsible for changes in protein isoform expression that add new functions beneficial for erythropoiesis. RNA-binding proteins adapt the translation of transcripts to the protein requirements of the cell, yielding mRNA with dynamic translation efficiency. Noncoding RNAs, such as microRNAs and lncRNAs, are indispensable for changing the translational efficiency and/or stability of targeted mRNAs to maintain the normal expression of genes related to erythropoiesis. N6-methyladenosine-dependent regulation of mRNA translation plays an important role in maintaining the expression programs of erythroid-related genes and promoting erythroid lineage determination. This review aims to describe our current understanding of the role of post-transcriptional regulation in erythropoiesis and erythroid-associated diseases, and to shed light on the physiological and pathological implications of the post-transcriptional regulation machinery in erythropoiesis. These may help to further enrich our understanding of the regulatory network of erythropoiesis and provide new strategies for the diagnosis and treatment of erythroid-related diseases.

Citing Articles

MicroRNAs: discovery, breakthrough, and innovation.

Yu J, Wang F Blood Sci. 2024; 6(4):e00210.

PMID: 39582618 PMC: 11584226. DOI: 10.1097/BS9.0000000000000210.

Expression of microRNA-155 in thalassemic erythropoiesis.

Penglong T, Pholngam N, Tehyoh N, Tansila N, Buncherd H, Thanapongpichat S PeerJ. 2024; 12:e18054.

PMID: 39314840 PMC: 11418816. DOI: 10.7717/peerj.18054.

Role of MiRNA in the Regulation of Blood Group Expression.

Kronstein-Wiedemann R, Kunzel S, Thiel J, Tonn T Transfus Med Hemother. 2024; 51(4):237-251.

PMID: 39135851 PMC: 11318968. DOI: 10.1159/000538866.

Human erythrocytes' perplexing behaviour: erythrocytic microRNAs.

Joshi U, Jani D, George L, Highland H Mol Cell Biochem. 2024; 480(2):923-935.

PMID: 39037663 DOI: 10.1007/s11010-024-05075-0.

A Review of Key Regulators of Steady-State and Ineffective Erythropoiesis.

Tichil I, Mitre I, Zdrenghea M, Bojan A, Tomuleasa C, Cenariu D J Clin Med. 2024; 13(9).

PMID: 38731114 PMC: 11084473. DOI: 10.3390/jcm13092585.

References

Jafari M, Ghadami E, Dadkhah T, Akhavan-Niaki H . PI3k/AKT signaling pathway: Erythropoiesis and beyond. J Cell Physiol. 2018; 234(3):2373-2385. DOI: 10.1002/jcp.27262. View

Tefferi A, Finke C, Lasho T, Hanson C, Ketterling R, Gangat N . U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions. Leukemia. 2018; 32(10):2274-2278. PMC: 6170397. DOI: 10.1038/s41375-018-0078-0. View

Oerum S, Meynier V, Catala M, Tisne C . A comprehensive review of m6A/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021; 49(13):7239-7255. PMC: 8287941. DOI: 10.1093/nar/gkab378. View

Conboy J . RNA splicing during terminal erythropoiesis. Curr Opin Hematol. 2017; 24(3):215-221. PMC: 5636188. DOI: 10.1097/MOH.0000000000000329. View

Zhang D, Cui Y, Li B, Luo X, Li B, Tang Y . A comparative study of the characterization of miR-155 in knockout mice. PLoS One. 2017; 12(3):e0173487. PMC: 5344489. DOI: 10.1371/journal.pone.0173487. View

Rahman M, Lin K, Bradley R, Abdel-Wahab O, Krainer A . Recurrent SRSF2 mutations in MDS affect both splicing and NMD. Genes Dev. 2020; 34(5-6):413-427. PMC: 7050488. DOI: 10.1101/gad.332270.119. View

Zucker J, Temm C, Czader M, Nalepa G . A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation. Pediatr Blood Cancer. 2015; 63(5):917-21. PMC: 5138049. DOI: 10.1002/pbc.25871. View

Obeng E, Chappell R, Seiler M, Chen M, Campagna D, Schmidt P . Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. Cancer Cell. 2016; 30(3):404-417. PMC: 5023069. DOI: 10.1016/j.ccell.2016.08.006. View

Zhang L, Flygare J, Wong P, Lim B, Lodish H . miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1. Genes Dev. 2011; 25(2):119-24. PMC: 3022257. DOI: 10.1101/gad.1998711. View

10.

Leecharoenkiat K, Tanaka Y, Harada Y, Chaichompoo P, Sarakul O, Abe Y . Plasma microRNA-451 as a novel hemolytic marker for β0-thalassemia/HbE disease. Mol Med Rep. 2017; 15(5):2495-2502. PMC: 5428399. DOI: 10.3892/mmr.2017.6326. View

11.

Rivkin N, Chapnik E, Birger Y, Yanowski E, Curato C, Mildner A . Rac1 functions downstream of miR-142 in regulation of erythropoiesis. Haematologica. 2017; 102(12):e476-e480. PMC: 5709115. DOI: 10.3324/haematol.2017.171736. View

12.

Steensma D . An RNA bestiary in splicing-mutant MDS. Blood. 2018; 132(12):1217-1219. DOI: 10.1182/blood-2018-07-859942. View

13.

Chan J, Hu X, Wang C, Xu Q . miRNA-152 targets GATA1 to regulate erythropoiesis in Chionodraco hamatus. Biochem Biophys Res Commun. 2018; 501(3):711-717. DOI: 10.1016/j.bbrc.2018.05.053. View

14.

Kesarwani A, Ramirez O, Gupta A, Yang X, Murthy T, Minella A . Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures. Oncogene. 2016; 36(8):1123-1133. PMC: 5311031. DOI: 10.1038/onc.2016.279. View

15.

Dolatshad H, Pellagatti A, Liberante F, Llorian M, Repapi E, Steeples V . Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes. Leukemia. 2016; 30(12):2322-2331. PMC: 5029572. DOI: 10.1038/leu.2016.149. View

16.

Cao L, Zhang P, Li J, Wu M . , a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote mRNA stability in human cells. Elife. 2017; 6. PMC: 5739540. DOI: 10.7554/eLife.30433. View

17.

Reimer K, Mimoso C, Adelman K, Neugebauer K . Co-transcriptional splicing regulates 3' end cleavage during mammalian erythropoiesis. Mol Cell. 2021; 81(5):998-1012.e7. PMC: 8038867. DOI: 10.1016/j.molcel.2020.12.018. View

18.

Kim E, Ilagan J, Liang Y, Daubner G, Lee S, Ramakrishnan A . SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. Cancer Cell. 2015; 27(5):617-30. PMC: 4429920. DOI: 10.1016/j.ccell.2015.04.006. View

19.

Edwards C, Ritchie W, Wong J, Schmitz U, Middleton R, An X . A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages. Blood. 2016; 127(17):e24-e34. PMC: 4850870. DOI: 10.1182/blood-2016-01-692764. View

20.

Morsia E, Torre E, Poloni A, Olivieri A, Rupoli S . Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications. Int J Mol Sci. 2022; 23(9). PMC: 9100530. DOI: 10.3390/ijms23094573. View